Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism - Takeaways - MDSpire

Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism

  • By

  • Rachel Zielinski

  • Shane J. Sacco

  • Martha Dillon

  • Maria Katsetos

  • Francesco S. Celi

  • June 30, 2026

  • 0 min

Share

  • 1

    Hypothyroidism, including subclinical hypothyroidism, is linked to dyslipidemia and increased cardiovascular risk.

  • 2

    In a study of 52 patients, levothyroxine treatment increased total and LDL cholesterol in those with mild subclinical hypothyroidism.

  • 3

    Median baseline TSH was 5.6 mIU/L and LDL-cholesterol was 121.0 mg/dL among the study participants.

  • 4

    Both treated and untreated groups experienced a decrease in median TSH levels, but only the treated group saw significant increases in cholesterol.

  • 5

    The findings suggest that levothyroxine therapy may paradoxically worsen lipid profiles in patients with mild subclinical hypothyroidism.

Original Source(s)

Treatment of mild subclinical hypothyroidism and its impact on lipid metabolism

  • by Rachel Zielinski, Shane J. Sacco, Martha Dillon, Maria Katsetos, Francesco S. Celi

  • June 30, 2026

Related Content

Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank

ACP Suggests First-Line Obesity Drugs

Semaglutide and tirzepatide had the greatest net benefit among evaluated treatments, the committee concluded.

Weight Loss, Comorbidity, and Complications After Single-anastomosis Sleeve Ileal Bypass (SASI): A Systematic Review and Meta-analysis